SPRY Financing Cash Flow
Ars Pharmaceuticals Inc · Financing Cash Flow
SPRY Financing Cash Flow
Latest reported$104.53Mperiod ending
SPRY TTM Cash from Financing ($33.44M → $104.53M)
TTM financing cash flow
High-resolution chart · PNG
SPRY financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 104,532,000 | |
| 104,032,000 | |
| 104,598,000 | |
| 174,383,000 | |
| 75,018,000 | |
| 72,866,000 | |
| 72,399,000 | |
| 3,288,000 | |
| 3,529,000 | |
| 5,838,000 | |
| 6,899,000 | |
| 198,913,000 | |
| 196,436,000 | |
| 192,959,000 | |
| 190,732,000 | |
| -2,812,000 | |
| -1,108,000 | |
| -166,000 | |
| 614,000 | |
| 12,272,000 | |
| 33,439,000 |